Pharmaceutical

Egyptian Drug Authority approves Lilly and EVA’s insulin injection

Eli Lilly and EVA Pharma have announced approval from the Egyptian Drug Authority for the human insulin glargine injection.

Dec 19, 2024 - 06:00
Egyptian Drug Authority approves Lilly and EVA’s insulin injection
Eli Lilly and EVA Pharma have announced approval from the Egyptian Drug Authority for the human insulin glargine injection.
Read the original article

Tags:

Previous Article

Gilead and Terray link to develop small-molecule therapies

Next Article

Novo Nordisk invests $1.2bn in new Denmark facility

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Gilead to acquire CymaBay for $4.3 billion, adding new treatment for liver disease

STAT+: Gilead to acquire CymaBay for $4.3 billion, addi...

Feb 13, 2024

Menarini signs agreement for Astellas’s rheumatoid arthritis therapy

Menarini signs agreement for Astellas’s rheumatoid arth...

Sep 13, 2023

STAT+: Leaked version of EFTA-India free trade deal sparks alarm over access to medicines

STAT+: Leaked version of EFTA-India free trade deal spa...

Feb 15, 2024